SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-069884
Filing Date
2024-08-15
Accepted
2024-08-15 19:54:54
Documents
2
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 6999
2 POWER OF ATTORNEY ea021158803ex24-1_biomotion.htm EX-24.1 9014
  Complete submission text file 0001213900-24-069884.txt   18121
Mailing Address C/O MORINGA ACQUISITION CORP 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 11040
Business Address
Levin Ilan (Reporting) CIK: 0001849189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213869

Mailing Address C/O MORINGA ACQUISITION CORP 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 11040
Business Address C/O MORINGA ACQUISITION CORP 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 11040 (212) 572-6395
Moringa Sponsor, LP (Reporting) CIK: 0001849192 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42253 | Film No.: 241213868

Mailing Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177
Business Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177 212-572-6395
Biomotion Sciences (Issuer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)